sues in a timely fashion and enable it to remediate, mitigate harm or report if required by law. The company is also subject to enforcement by state attorneys general who were given authority to enforce HIPAA under the Health Information Technology for Economic and Clinical Health Act. The company is also required to maintain accurate information on and control over sales and distributors’ activities that might fall within the purview of the Foreign Corrupt Practices Act, its books and records provisions and its anti-bribery provisions. History Myriad Genetics, Inc. was founded in 1991.
myriad genetics inc
(MYGN:Consolidated Issue Listed on NASDAQ Global Select )
320 Wakara Way
Salt Lake City, UT 84108
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for MYGN.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact MYRIAD GENETICS INC, please visit www.myriad.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.